Post

M&A in medical devices in Japan increased in Q1 2024

In the Japanese medical devices industry, there were 6 M&A deals announced in Q1 2024, worth a total value of …

How precision and personalized medicine M&A performed in the medical devices industry in Q1 2024

Analysis of the key themes driving M&A activity reveals that precision and personalized medicine accounted for 2 medical devices deals …

How ecommerce M&A performed in the medical devices industry in Q1 2024

Analysis of the key themes driving M&A activity reveals that ecommerce accounted for 2 medical devices deals announced in Q1 …

Endologix hits primary endpoints in one-year follow-up data for DETOUR2 trial

Endologix has reported positive one-year results from its DETOUR2 trial evaluating its fully percutaneous transmural arterial bypass therapy. The prospective, single-arm, …

Qiagen’s QIAstat-Dx respiratory diagnostic wins FDA clearance

The US Food and Drug Administration (FDA) has cleared Qiagen’s QIAstat-Dx Respiratory Panel Plus syndromic test, designed for pathogen detection …